| Ticker Details |
Cellectis S.A.
Cellectis SA is a gene-editing company, employing its core proprietary technologies to develop products in the emerging field of immuno-oncology. Its two segment includes Therapeutics and Plants.
|
| IPO Date: |
March 25, 2015 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$416.35M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.36 | 2.54%
|
| Avg Daily Range (30 D): |
$0.12 | 2.69%
|
| Avg Daily Range (90 D): |
$0.12 | 2.99%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.19M |
| Avg Daily Volume (30 D): |
.07M |
| Avg Daily Volume (90 D): |
.11M |
| Trade Size |
| Avg Trade Size (Sh.): |
131 |
| Avg Trade Size (Sh.) (30 D): |
105 |
| Avg Trade Size (Sh.) (90 D): |
129 |
| Institutional Trades |
| Total Institutional Trades: |
213 |
| Avg Institutional Trade: |
$1.71M |
| Avg Institutional Trade (30 D): |
$1.38M |
| Avg Institutional Trade (90 D): |
$1.38M |
| Avg Institutional Trade Volume: |
.08M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.75M |
| Avg Closing Trade (30 D): |
$1.38M |
| Avg Closing Trade (90 D): |
$1.38M |
| Avg Closing Volume: |
81.89K |
|
|
|
|
|
